Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  227 results for "%22AUSTRALIA%22"

Your Filters

Publisher : springer verlag Subject : biomarkers Subject : cardiovascular diseases Subject : diabetes mellitus, type 2 Subject : glucose intolerance Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

  • Source: Calcified tissue international [Calcif Tissue Int] 2019 Jun; Vol. 104 (6), pp. 599-604. Date of Electronic Publication: 2019 Jan 24.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
Academic Journal

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

  • Source: Diabetologia [Diabetologia] 2024 May; Vol. 67 (5), pp. 837-849. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis.

  • Authors : Morton JI; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia. .; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. .

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/complications

  • Source: Diabetologia [Diabetologia] 2023 Apr; Vol. 66 (4), pp. 642-656. Date of Electronic Publication: 2022 Nov 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial.

  • Authors : Waijer SW; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Vart P

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/complications

  • Source: Diabetologia [Diabetologia] 2022 Jul; Vol. 65 (7), pp. 1085-1097. Date of Electronic Publication: 2022 Apr 21.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA 1c , disease duration and treatment intensity: results from the CANVAS Program.

  • Authors : Young TK; The George Institute for Global Health, UNSW, Sydney, NSW, Australia.; Li JW

Subjects: Canagliflozin/Canagliflozin/Canagliflozin/*therapeutic use ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications

  • Source: Diabetologia [Diabetologia] 2021 Nov; Vol. 64 (11), pp. 2402-2414. Date of Electronic Publication: 2021 Aug 26.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trial.

  • Authors : Sen T; Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, the Netherlands.; Li J

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Canagliflozin/Canagliflozin/Canagliflozin/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Diabetologia [Diabetologia] 2021 Oct; Vol. 64 (10), pp. 2147-2158. Date of Electronic Publication: 2021 Aug 20.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Association between sleep duration and mortality risk among adults with type 2 diabetes: a prospective cohort study.

  • Authors : Wang Y; Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, 185 Donghu Road, Wuchang District, Wuhan, 430071, Hubei, China.; Huang W

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*epidemiology ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*mortality ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Diabetologia [Diabetologia] 2020 Nov; Vol. 63 (11), pp. 2292-2304. Date of Electronic Publication: 2020 Jul 16.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.

  • Authors : Harris K; The George Institute for Global Health, UNSW Sydney, Level 10, King George V Building, 83-117 Missenden Road, Camperdown, Sydney, NSW, 2050, Australia. .; Oshima M

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Fatty Acids/Fatty Acids/Fatty Acids/*blood

  • Source: Diabetologia [Diabetologia] 2020 Aug; Vol. 63 (8), pp. 1637-1647. Date of Electronic Publication: 2020 May 08.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course.

  • Authors : Huebschmann AG; Center for Women's Health Research, University of Colorado School of Medicine, MS C263, 12348 E. Montview Boulevard, Aurora, CO, 80045, USA.; Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*epidemiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/etiology

  • Source: Diabetologia [Diabetologia] 2019 Oct; Vol. 62 (10), pp. 1761-1772. Date of Electronic Publication: 2019 Aug 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Moderate weight change following diabetes diagnosis and 10 year incidence of cardiovascular disease and mortality.

  • Authors : Strelitz J; MRC Epidemiology Unit, Institute of Metabolic Science, Cambridge Biomedical Campus, University of Cambridge School of Clinical Medicine, Box 285, Cambridge, CB2 0QQ, UK. .; Ahern AL

Subjects: Weight Gain* ; Weight Loss*; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*complications

  • Source: Diabetologia [Diabetologia] 2019 Aug; Vol. 62 (8), pp. 1391-1402. Date of Electronic Publication: 2019 May 07.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  227 results for "%22AUSTRALIA%22"